These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 33539853)

  • 1. Microarray patches enable the development of skin-targeted vaccines against COVID-19.
    Korkmaz E; Balmert SC; Sumpter TL; Carey CD; Erdos G; Falo LD
    Adv Drug Deliv Rev; 2021 Apr; 171():164-186. PubMed ID: 33539853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: The status and perspectives in delivery points of view.
    Chung JY; Thone MN; Kwon YJ
    Adv Drug Deliv Rev; 2021 Mar; 170():1-25. PubMed ID: 33359141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.
    Iqbal Yatoo M; Hamid Z; Parray OR; Wani AH; Ul Haq A; Saxena A; Patel SK; Pathak M; Tiwari R; Malik YS; Sah R; Rabaan AA; Rodriguez Morales AJ; Dhama K
    Hum Vaccin Immunother; 2020 Dec; 16(12):2891-2904. PubMed ID: 32703064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
    Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
    Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
    Mudgal R; Nehul S; Tomar S
    Hum Vaccin Immunother; 2020 Dec; 16(12):2921-2931. PubMed ID: 32931361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses.
    Nguyen TT; Nguyen TTD; Tran NM; Nguyen HT; Vo GV
    Pharm Dev Technol; 2022 Jan; 27(1):83-94. PubMed ID: 34802372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
    Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
    Front Immunol; 2021; 12():697074. PubMed ID: 34262569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
    Del Fresno C; García-Arriaza J; Martínez-Cano S; Heras-Murillo I; Jarit-Cabanillas A; Amores-Iniesta J; Brandi P; Dunphy G; Suay-Corredera C; Pricolo MR; Vicente N; López-Perrote A; Cabezudo S; González-Corpas A; Llorca O; Alegre-Cebollada J; Garaigorta U; Gastaminza P; Esteban M; Sancho D
    Front Immunol; 2021; 12():748103. PubMed ID: 34867974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Xia D; Jin R; Byagathvalli G; Yu H; Ye L; Lu CY; Bhamla MS; Yang C; Prausnitz MR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34670842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and prospective computational approaches and challenges for developing COVID-19 vaccines.
    Hwang W; Lei W; Katritsis NM; MacMahon M; Chapman K; Han N
    Adv Drug Deliv Rev; 2021 May; 172():249-274. PubMed ID: 33561453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.
    Danladi J; Sabir H
    J Neuroimmunol; 2021 Sep; 358():577632. PubMed ID: 34186336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
    Chakraborty S; Mallajosyula V; Tato CM; Tan GS; Wang TT
    Adv Drug Deliv Rev; 2021 May; 172():314-338. PubMed ID: 33482248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.